Search for:
Search
Rubius Therapeutics
About Us
Our Story
Leadership Team
Board of Directors
Scientific Advisory Board
Giving Back
Vision & Values
Diversity Statement
Our Science
Overview
Red Cell Therapeutics
TM
Therapeutic Modalities
MOA Video
Manufacturing
Publications
Our Pipeline
Pipeline Overview
Therapeutic Areas
Clinical Trials
RTX-240 – Solid Tumors
RTX-224 – Solid Tumors
Patient Access
Investors and Media
Company Overview
Press Releases
Events & Presentations
Publications
Stock Information
Governance
Financials & Filings
Quarterly Results
Careers
Overview
Culture Video
Current Opportunities
Cambridge, MA
Smithfield, RI
Rubius Rewards & Benefits
Contact
Menu
Search
Engineered Red Blood Cells as an Off-the-Shelf Allogeneic Anti-Tumor Therapeutic